IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 92 filers reported holding IGM BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,000 | +4.0% | 6,203 | +13.9% | 0.00% | – |
Q2 2023 | $50,000 | -25.4% | 5,445 | +11.3% | 0.00% | – |
Q1 2023 | $67,000 | -26.4% | 4,892 | -9.3% | 0.00% | – |
Q4 2022 | $91,000 | -8.1% | 5,395 | +24.6% | 0.00% | – |
Q3 2022 | $99,000 | +167.6% | 4,329 | +110.5% | 0.00% | – |
Q2 2022 | $37,000 | -43.9% | 2,057 | -17.8% | 0.00% | – |
Q1 2022 | $66,000 | -38.3% | 2,503 | -31.4% | 0.00% | – |
Q4 2021 | $107,000 | -94.3% | 3,651 | -87.3% | 0.00% | – |
Q3 2021 | $1,890,000 | -20.6% | 28,744 | +0.4% | 0.00% | -100.0% |
Q2 2021 | $2,381,000 | +33.6% | 28,621 | +23.2% | 0.00% | 0.0% |
Q1 2021 | $1,782,000 | +901.1% | 23,229 | +1052.8% | 0.00% | – |
Q4 2020 | $178,000 | +19.5% | 2,015 | +0.1% | 0.00% | – |
Q3 2020 | $149,000 | +1.4% | 2,012 | 0.0% | 0.00% | – |
Q2 2020 | $147,000 | +10.5% | 2,012 | -15.4% | 0.00% | – |
Q1 2020 | $133,000 | +49.4% | 2,379 | +1.8% | 0.00% | – |
Q4 2019 | $89,000 | – | 2,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
RA Capital Management | 937,500 | $7,828,125 | 0.15% |
Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |